InflaRx (IFRX) FCF Margin (2023 - 2026)
InflaRx's (IFRX) quarterly FCF Margin came in at 6429.87% in Q2 2026, up 1268624.0% year-over-year from N/an in Q2 2025, and down 146.38% quarter-over-quarter from 13862.11% in Q4 2025.
Powered by 
Analysis
InflaRx (IFRX) FCF Margin (2023 - 2026) Analysis & Trends
InflaRx has disclosed FCF Margin across 4 years of filings, most recently posting 6429.87% for Q2 2026.
- In Q2 2026, FCF Margin rose 1268624.0% year-over-year to 6429.87%; the TTM figure through Jun 2026 stood at 34924.11% (down 1357173.0% YoY), while the FY2025 annual figure was 120004.89%, down 9074491.0% from the prior year.
- FCF Margin came in at 6429.87% for Q2 2026 at InflaRx, down from 13862.11% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 2808019.15% in Q4 2024 to a low of 474199.34% in Q4 2023.
- Average FCF Margin over 4 years is 181582.0%, with a median of 19116.12% recorded in 2025.
- Year-over-year, FCF Margin soared 328221849 bps in 2024 and plunged 279415704 bps in 2025.
- Over 4 years, FCF Margin stood at 474199.34% in 2023, then surged by 692 bps to 2808019.15% in 2024, then sank by 100 bps to 13862.11% in 2025, then plunged by 146 bps to 6429.87% in 2026.
- Per Business Quant data, the three most recent FCF Margin figures were 6429.87% in Q2 2026, 13862.11% in Q4 2025, and 37566.05% in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 34.70% |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 44.00% |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 30.39% |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 13.35% |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -388.28% |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 22.62% |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 14.91% |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -18,629.40% |
| 10 | InflaRx | 139.29 Mn | -44.96 Mn | 2.74 Mn | -6,429.87% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6,429.87% |
| Dec 31, 2025 | 13,862.11% |
| Sep 30, 2025 | -37,566.05% |
| Jun 30, 2025 | -19,116.12% |
| Mar 31, 2025 | -38,863.46% |
| Dec 31, 2024 | 2,808,019.15% |
| Sep 30, 2024 | -7,799.75% |
| Jun 30, 2024 | -190,687.89% |
| Mar 31, 2024 | -41,214.02% |
| Dec 31, 2023 | -474,199.34% |
| Sep 30, 2023 | -8,602.70% |